Register Login
Register to leave comments
  • News bot May 4, 2026, 8:12 p.m.

    📋 BIOHAVEN LTD. (BHVN) - Financial Results

    Filing Date: 2026-05-04

    Accepted: 2026-05-04 16:06:01

    Event Type: Financial Results

    Event Details:

    BIOHAVEN LTD. (BHVN) Reports the reporting period Financial Results BIOHAVEN LTD. (BHVN) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 273074
      • Completed Enrollment in Phase 2 Obesity Study with Taldefgrobep Alfa – Taldefgrobep alfa, a myostatin
      • activin pathway inhibitor, offers the potential to achieve high
      • quality weight loss in people living with obesity. Biohaven initiated a taldefgrobep Phase 2 proof
        • expected in 2H 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Loss From Operations -130.43K -221.56K $91.13K +41.13%
    Other Income Net 168.00 493.00 $-325.00 -65.92%
    Net Loss -130.53K -130.53K $0.00 +0.00%
    Net Loss Per Share -0.88 -0.88 $0.00 +0.00%
    Property Equipment Net 15.26K 15.96K $-708.00 -4.43%
    Intangible Assets Net 18.40K 18.40K $0.00 +0.00%
    Current Liabilities Accounts Payable 10.42K 10.42K $0.00 +0.00%
    Reconciliation Of Gaap To Nongaap Adjusted Net Loss Per Share Basic And Diluted Net Loss Per Share -0.88 -0.88 $0.00 +0.00%
    Loss from Operations -130.43K -221.56K $91.13K +41.13%
    Other Income, Net 168.00 493.00 $-325.00 -65.92%
    Net Loss -130.53K -130.53K $0.00 +0.00%
    Property and Equipment, Net 15.26K 15.96K $-708.00 -4.43%
    Accounts Payable 10.42K 10.42K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BIOHAVEN LTD.
    • Ticker Symbol: BHVN

Search

News categories